Waqqas Afif

15PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersHorticultural crop improvement (incl. selection and breeding)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Agro-ecosystem function and predictionInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 02, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled Analysis.

|May 01, 2026
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Nov 13, 2025
Personalizing IL-23 Inhibitor Therapy in IBD: Current Evidence and Future Directions in Therapeutic Drug Monitoring and Dose Optimization.

Alessandro Pedicelli, Talat Bessissow, Waqqas Afif

|Sep 19, 2025
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis.

Gustavo Drügg Hahn, Peter Laszlo Lakatos, Chelsea Maedler-Kron

|Jul 29, 2025
Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis.

Steven Li Fraine, Victoria Marcus, Chelsea Maedler Kron

Pageof 3

Frequent Collaborators

4 joint publications

Peter Laszlo Lakatos

4 joint publications

Talat Bessissow

4 joint publications

Gustavo Drügg Hahn

3 joint publications

Gary Wild